Inflammation in Diabetic Nephropathy

Inflammation in Diabetic Nephropathy

Diabetic nephropathy is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. This review examines the evidence for inflammation in the development and progression of diabetic nephropathy in both experimental and human diabetes, and provides an update on r...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Andy K.H. Lim, Greg H. Tesch
Format:	Revisão
Jezik:	angleščina
Izdano:	2012
Online dostop:	https://doi.org/10.1155/2012/146154 https://downloads.hindawi.com/journals/mi/2012/146154.pdf
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Inflammation in Diabetic Nephropathy
od: Lim, Andy K. H., et al.
Izdano: (2012)

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
od: Andy K.H. Lim, et al.
Izdano: (2009)

Diabetic nephropathy &ndash; complications and treatment
od: Andy K.H. Lim
Izdano: (2014)

Diabetic nephropathy – complications and treatment
od: Lim, Andy KH
Izdano: (2014)

Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
od: F. Y. Chow, et al.
Izdano: (2004)

Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
od: Andy K.H. Lim, et al.
Izdano: (2010)

Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
od: Fiona Chow, et al.
Izdano: (2003)

Diabetic nephropathy and inflammation
od: Montserrat B. Duran-Salgado
Izdano: (2014)

Diabetic nephropathy and inflammation
od: Duran-Salgado, Montserrat B, et al.
Izdano: (2014)

ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in <i>Nos3</i>-Deficient Mice
od: Greg H. Tesch, et al.
Izdano: (2015)

Epigenetics and Inflammation in Diabetic Nephropathy
od: Baoyi Shao, et al.
Izdano: (2021)

Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
od: Fiona YF CHOW, et al.
Izdano: (2005)

Epigenetics and Inflammation in Diabetic Nephropathy
od: Shao, Bao-Yi, et al.
Izdano: (2021)

Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice
od: Andy K.H. Lim, et al.
Izdano: (2008)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
od: Juan F. Navarro‐González, et al.
Izdano: (2006)

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
od: L Adhikary, et al.
Izdano: (2004)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
od: Navarro, Juan F., et al.
Izdano: (2006)

Immune Cells and Inflammation in Diabetic Nephropathy
od: Zihan Zheng, et al.
Izdano: (2015)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
od: Shirong Zheng, et al.
Izdano: (2016)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
od: Desirée Luis-Rodríguez
Izdano: (2012)

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
od: Qi Jin, et al.
Izdano: (2023)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
od: Luis-Rodríguez, Desirée, et al.
Izdano: (2012)

Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy
od: Yang, Wen-xia, et al.
Izdano: (2021)

Diabetic Nephropathy
od: Lionel H. Opie, et al.
Izdano: (2002)

Cellular Basis of Diabetic Nephropathy
od: Maria Luiza Caramori, et al.
Izdano: (2002)

Prognosis in diabetic nephropathy.
od: H.‐H. Parving, et al.
Izdano: (1989)

Diabetic nephropathy
od: Zelmanovitz, Themis, et al.
Izdano: (2009)

Prognosis in diabetic nephropathy.
od: Parving, H. H., et al.
Izdano: (1989)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
od: Keizo Kanasaki, et al.
Izdano: (2013)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
od: Sandra Rayego‐Mateos, et al.
Izdano: (2020)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
od: Susan B. Gurley, et al.
Izdano: (2018)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
od: Kanasaki, Keizo, et al.
Izdano: (2013)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
od: Gurley, Susan B., et al.
Izdano: (2018)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
od: Rayego-Mateos, Sandra, et al.
Izdano: (2020)

Abnormal liver function tests associated with severe rhabdomyolysis
od: Andy K.H. Lim
Izdano: (2020)

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
od: Markku Saraheimo, et al.
Izdano: (2003)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
od: Julie Lin, et al.
Izdano: (2008)

Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
od: Miao Lin, et al.
Izdano: (2011)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
od: Lin, Julie, et al.
Izdano: (2008)

Silent diabetic nephropathy
od: Samar M. Said, et al.
Izdano: (2016)